(Q54278809)
Statements
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha (English)
P. Lissoni
S. Barni
A. Ardizzoia
S. Crispino
F. Paolorossi
C. Archili
M. Vaghi
1 January 1992
28
1
92-96